Surveillance in stage I testicular cancer

APMIS

Volumn 111, Issue 1, 2003, Pages 76-85

  Daugaard, Gedske ^a,b   Petersen, Peter Meidahl ^a   RØrth, Mikael ^a   Dieckmann, Klaus Peter ^b   Kliesch, Sabine ^b   Oliver, Tim ^b   Scholz, Michael ^b   Von Eyben, Finn Edler ^b  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

Nonseminoma; Seminoma; Stage I testicular cancer; Surveillance

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CAUSE OF DEATH; CONFERENCE PAPER; FOLLOW UP; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEMINOMA; TESTIS CARCINOMA; TESTIS NONSEMINOMA CANCER;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; COMBINED MODALITY THERAPY; DENMARK; GERMINOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; ORCHIECTOMY; PHYSICAL EXAMINATION; POPULATION SURVEILLANCE; SEMINOMA; SURVIVAL RATE; TESTICULAR NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038222521     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2003.11101111.x     Document Type: Conference Paper

References (56)

1. Sonneveld, Hoekstra O, Van Der Graaf, et al. The changing distribution of stages in nonseminomatous testicular germ cell tumours from 1977 to 1996. Br J Urol 1999;84:68-74.
2. Aass N, Fosså SD, Host H. Acute and subacute side effects due to infra-diaphragmatic radiotherapy for testicular cancer: A prospective study. Int J Radiat Oncol Biol Phys 1992;22:1057-64.
3. Østerlind A, Rørth M, Prener A. Second cancer following cancer of the male genital system in Denmark, 1943-80. Natl Cancer Inst Monogr 1985;68:341-3.
4. Fosså SD, Aass N, Kaalhus O. Long term morbidity after infradiaphragmatic radiotherapy in young men with testicular cancer. Cancer 1989;64:404-8.
5. Stein ME, Steiner M, Lachter J, Kessel I, Moskovitz B, Kuten A. Second primary cancer in irradiated stage I testicular seminoma. Strahlenther Onkol 1993;11:672-7.
6. Yeoh E, Razali M, O'Brien PC. Radiation therapy for early stage seminoma of the testis. Analysis of survival and gastrointestinal toxicity in patients treated with modern megavoltage techniques over 10 years. Australas Radiol 1993;37:367-9.
7. Peckham MJ, Barrett A, Husband JE, et al. Orchidectomy alone in testicular stage I non-seminomatous germ cell tumours. Lancet 1982;2:678-80.
8. Rørth M, Jacobsen GK, von der Maase H, et al. Surveillance alone versus radiotherapy after orchidectomy for clinical stage I nonseminomatous testicular cancer. J Clin Oncol 1991;9:1543-8.
9. Schultz HP, von der Maase H, Rørth M, Pedersen M, Nielsen ES, Walbom-Jørgensen S. Testicular seminoma in Denmark 1976-1980. Acta Radiol Oncol 1984;23:263-70.
10. Zagars GK. Management of stage I seminoma: radiotherapy. In: Horwich A, editor. Testicular cancer. Investigation and management. London: Chapman and Hall Medical, 1991:83-107.
11. Gels ME, Hoekstra H J, Sleijfer DTH, et al. Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: A single-center 10-year experience. J Clin Oncol 1995;13(5):1188-94.
12. Fosså SD, Jacobsen AB, Aass N, et al. How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources? Br J Cancer 1994;70:1156-60.
13. Sharir S, Foster RS, Jewett MAS, et al. Optimizing follow-up for early stage nonseminomatous testicular cancer. J Urol 1996;155:327a.
14. White PM, Adamson DJA, Howard GCW, et al. Imaging of the thorax in the management of germ cell testicular tumours. Clin Radiol 1999;54:207-11.
15. Harvey ML, Geldart TR, Duell R, Mead GM, Tung K. Routine computerized tomographic scans of thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer - a necessary risk? Ann Oncol 2002;13:237-42.
16. See WA, Hoxie L. Chest staging in testis cancer patients: Imaging modality selection based upon risk assessment as determined by abdominal computerized tomography scan results. J Urol 1993;150:874-8.
17. Freedman LS, Parkinson MC, Jones WG, et al. Histopathology in the prediction of relapse in patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 1987;2:294-8.
18. Warde PR, Gospodarowicz MK, Goodman PJ, et al. Results of a policy of surveillance in stage I testicular seminoma. Int J Radiat Oncol Biol Phys 1993;27:11-5.
19. von der Maase H, Specht L, Jacobsen GK, et al. Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 1993;29A(14):1931-4.
20. Horwich A, Alsanjari N, Hern RA, Nicholls J, Dearnaley DP, Fisher C. Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 1992;65:775-8.
21. Read G, Stenning SP, Cullem MH, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. J Clin Oncol 1992;10:1762-8.
22. Colls BM, Harvey VJ, Skelton L, et al. Results of the surveillance policy of stage I non-seminomatous germ cell testicular tumours. Br J Urol 1992; 70:423-8.
23. Alexandre J, Fizazi K, Mahé C, et al. Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse. Eur J Cancer 2001;37:576-82.
24. Hoskin P, Dilly S, Easton D, Horwich A, Hendry W, Peckham MJ. Prognostic factors in stage I nonseminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. J Clin Oncol 1986;4:1031-6.
25. Sturgeon JFG, Jewett MAS, Alison RE, et al. Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors. J Clin Oncol 1992;10:564-8.
26. Swanson D, Johnson DE. M.D. Anderson experience with surveillance for clinical stage I disease. In: Johnson DE, Logothetis CJ, Von Eschenbach AC, editors. Systemic therapy for genitourinary cancers. Chicago, Year Book Medical Publishers, 1989:304-11.
27. Nicolai N, Pizzocaro G. A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. J Urology 1995;154:1045-9.
28. Raghavan D, Colls B, Levi J, et al. Surveillance for stage I nonseminomatous germ cell tumours of the testis: the optimal protocol has not yet been defined. Br J Urol 1988;61:522-6.
29. Gelderman WAH, Schraffordt Koops H, Sleijfer DTH, et al. Orchidectomy alone in stage I nonseminomatous testicular germ cell tumors. Cancer 1987;59:578-80.
30. Crawford SM, Rustin GJS, Begent RHJ, Newlands ES, Bagshawe KD. Safety of surveillance in the management of stage I anaplastic germ cell tumours of the testis. Br J Urol 1988;61:250-3.
31. GermaLluch JR, Climent MA, Villavicencio H, et al. Treatment of stage I testicular tumours. Br J Urol 1993;71:473-7.
32. Thompson PI, Nixon J, Harvey VJ. Disease relapse in patients with stage I non-seminomatous germ cell tumor of the testis on active surveillance. J Clin Oncol 1988;6:1597-603.
33. Johnson DE, Lo RK, Eschenbach AC von, Swanson DA. Surveillance alone for patients with clinical stage I nonseminomatous germ cell tumors of the testis: preliminary results. J Urol 1984;131:491-3.
34. Patel SR, Richardson RL, Kvols L, Zincke H. Observation after orchiectomy in clinical stage I nonseminomatous germ cell tumor of testis. Am J Clin Oncol 1990;13:379-81.
35. Sujka SK, Huben RP. Clinical stage I nonseminomatous germ cell tumors of testis. Urology 1991;38:29-31.
36. Gez E, Wygoda M, Nussbaum N, Figer A, Igal Gil R, Inbal M. Surveillance in patients with stage I testicular nonseminomatous germ cell tumors. Cancer Invest 1993;11:10-4.
37. Sogani PC. Evolution of the management of stage I nonseminomatous germ-cell tumor of the testis. Urol Clin 1991;18:561-73.
38. Ondrus, Hornak M. Orchiectomy alone for clinical stage I nonseminomatous germ cell tumors of the testis (NSGCTT): A minimum follow-up period of 5 years. Tumori 1994;80:362-4.
39. Boyer MJ, Tattersall MH, Findlay MP, Grygiel J, Rogers J. Active surveillance after orchiectomy for non-seminomatous testicular germ cell tumors: late relapse may occur. Urology 1997;50:588-92.
40. Pizzocaro G, Zanoni F, Milani A, et al. Orchiectomy alone in clinical stage I nonseminomatous testis cancer: a critical appraisal. J Clin Oncol 1986;4:35-40.
41. Francis R, Bower M, Brunström L, et al. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer 2000;36:1925-32.
42. Roeleveld TA, Horenblas S, Meinhardt W, van der Vijver M, Kooi M, ten Bokkel Huinink WW. Surveillance can be standard care for stage I non-seminomatous testicular tumors and even high risk patients. J Urol 2001;166:2166-70.
43. Stiggelbout AM, Kiebert GM, de Haes JCJM, et al. Surveillance versus adjuvant chemotherapy in stage I non-seminomatous testicular cancer: A decision analysis. Eur J Cancer 1996;32A(13):2267-74.
44. Cullen MH, Billingham LJ, Cook J, Woodroffe CM. Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists. Br J Cancer 1996;74:1487-91.
45. Baniel J, Foster RS, Gonin R, et al. Late relapse of testicular cancer. J Clin Oncol 1995;13:1170-5.
46. Sogani PC, Perrotti M, Herr HW, Fair WR, Thaler HT, Bosl G. Clinical stage I testis cancer: Long-term outcome of patients on surveillance. J Urology 1998;159:855-8.
47. Baniel J, Roth BJ, Foster RS, Donohue JP. Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors. Ann Surg Oncol 1996;3(1):86-93.
48. Sharda NN, Kinsella TJ, Ritter MA. Adjuvant radiation versus observation: A cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 1996;14(11):2933-9.
49. von der Maase H, Rørth M, Walbom-Jørgensen S, et al. Carcinoma in situ of the contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J 1986;293:1398-401.
50. Scheiber K, Ackermann D, Studer UE. Bilateral testicular germ cell tumors: A report of 20 cases. J Urol 1987;138:73-6.
51. Dieckmann KP, Brockmann W, Brosig W, et al. Bilateral testicular germ cell tumors. Report of nine cases and review of the literature. Cancer 1986;57:1254-8.
52. Østerlind A, Berthelsen JG, Abildgaard N, et al. Risk of bilateral testicular germ cell cancer in Denmark 1960-1984. J Natl Cancer Inst 1991;83:1391-5.
53. von der Maase H, Giwercman A, Skakkebæk NE: Radiation treatment of Carcinoma-in-situ of testis. Lancet 1986;i:624-5.
54. von der Maase H, Giwercman A, Møller J, et al. Management of carcinoma in situ of the testis. Int J Androl 1987;10:209-20.
55. Giwercman A, von der Maase H, Berthelsen J, et al. Localized irradiation of testis with carcinomain-situ: effects on Leydig cell function and erradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 1991;73:596-603.
56. Petersen PM, Giwercman A, Daugaard G, et al. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma in situ. J Clin Oncol 2002;20:1537-43.